We maintain our Neutral recommendation on Simpar (Ba3/BB-/BB-) at the issuer level and move our preferred bond to the VAMOBZ 9.200% 2031 notes, with a bond-level Overweight, from the MOVIBZ 9.700% 2033s, which we lower to Neutral. This is a different Neutral from our 2Q26 report. Then, we judged that thin debt-service capacity left too little headroom for an issuer-level call despite attractive bonds. Since then, the four Simpar bonds maturing after 2029 have widened 166–364 bps, against 57 bps for the EM BB corporate index. Operating performance has improved, but the financing environment the credit depends on has deteriorated materially. We think the two shifts broadly offset at the issuer level. The value is clearest in VAMOBZ, which pairs the widest spread in the group with the shortest duration among the longer bonds, while each of the other bonds carries a specific drawback in duration, subordination or size.
The constraints behind our 2Q26 Neutral are still in place. EBITDA interest coverage of 1.97x and EBIT coverage of 1.23x are essentially unchanged from June, so interest still takes more than four-fifths of EBIT. LTM net free cash flow was negative R$2.07 billion, and leverage fell because EBITDA rose while net reported debt increased. Movida passed the utilization test we set in our 2Q26 report, but the improvement has yet to reach debt-service capacity.

